"Since its inception in 1953, Baptist Health Floyd has emerged to be an outstanding regional healthcare provider. Its medical staff is a well-built team of more than 600 physicians, representing a variety of specialties. The hospital currently employs over 2,000 employees. The hospital has achieved Pathway to Excellence designation for excellence in nursing services from the American Nurses Credentialing Center's (ANCC) Recognition Program."

During the past decade, Baptist Health Floyd conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baptist Health Floyd" #1 sponsor was "National Cancer Institute (NCI)" with 9 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Aziyo Biologics, Inc." with 1 trials sponsored, "Christine M. Kleinert Institute for Hand and Microsurgery" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baptist Health Floyd" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Baptist Health" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Jewish Hospital and St. Mary's Healthcare" with 1 trials as a collaborator and "Kleinert, Kutz and Associates" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Baptist Health Floyd" are "Colon Adenocarcinoma" (2 trials), "Locally Advanced Bladder Urothelial Carcinoma" (2 trials), "Locally Advanced Ureter Urothelial Carcinoma" (2 trials), "Locally Advanced Urothelial Carcinoma" (2 trials) and "Ovarian Carcinoma" (2 trials). Many other conditions were trialed in "Baptist Health Floyd" in a lesser frequency.

Most popular intervention types in "Baptist Health Floyd" are "Other" (12 trials), "Drug" (10 trials), "Procedure" (9 trials), "Biological" (8 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (7 trials), "Quality-of-Life Assessment" (6 trials), "Computed Tomography" (5 trials), "Magnetic Resonance Imaging" (5 trials) and "Nivolumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Baptist Health Floyd" are 14 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Baptist Health Floyd". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Baptist Health Floyd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baptist Health Floyd, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Baptist Health Floyd has several departments that took part in Clinical trials: "Cancer Care Center" - 28 trials, "Center for Cancer Care, Inc., P.C." - 11 trials, "Cancer Center of Indiana" - 3 trials